TruAlt Bioenergy Limited has submitted a regulatory disclosure to BSE Limited and the National Stock Exchange of India Limited regarding an upcoming board meeting.
The Board of Directors meeting is scheduled to be held on Friday, October 23, 2026. The primary agenda for this meeting is to consider and approve the company's Unaudited Financial Results for both Standalone and Consolidated operations. These results cover the financial period ending September 30, 2026, representing the company's second quarter and first half of fiscal year 2027.
The company confirms that the trading window for securities remains closed for all designated persons and their immediate relatives. This closure will continue for 48 hours after the unaudited financial results (both standalone and consolidated) are officially submitted to the stock exchanges.
This intimation is made in compliance with Regulation 29(1) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended. The disclosure will also be made available on the company's website at www.trualtbioenergy.com.
The communication was digitally signed by Monu Kumar, who holds the position of Company Secretary & Compliance Officer (Membership No.: A38853).